Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.

Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.

Type 1 diabetes (T1D) results from autoimmune destruction of insulin producing β cells of the pancreatic islets. Curbing autoimmunity at the initiation of T1D can result in recovery of residual β cells and consequently remission of diabetes. Here we report a cell-based therapy for autoimmune diabete...

Full description

Bibliographic Details
Main Authors: Reza B Jalili, Yun Zhang, Azadeh Hosseini-Tabatabaei, Ruhangiz T Kilani, Mohsen Khosravi Maharlooei, Yunyuan Li, Sanam Salimi Elizei, Garth L Warnock, Aziz Ghahary
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4713151?pdf=render

Internet

http://europepmc.org/articles/PMC4713151?pdf=render

Similar Items